Intelligent Bio Solutions IncINBS
Price$1.66

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.2M+38.1% YoYTTM through 30 Jun 2026
Net Income -$12.4MTTM through 30 Jun 2026
Free Cash Flow -$12.1MTTM through 30 Jun 2026

Margins

Current
Gross Margin50.5%
EBITDA Margin-276.7%
Operating Margin-269.6%
Net Margin-294.9%

Returns

-133.2%ROE
-78.1%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.10x
Net Debt-$6.9Mnet cash position
Cash & Equivalents$4M

Quality Metrics

Altman Z-Score-11.16
Piotroski F-Score3 / 9
FCF Margin-285.9%
Rule of 40-284.2

Multi-Year Trend

Revenue
'21'22'23'24'25'26
FY2026: $4.2M
Diluted EPS-$8.44TTM
'22'23'24'25'26
FY2026: $-8.44

Dividend

No dividend

Capital Allocation

Capex Intensity3.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.